News & Insights

Blumberg Capital portfolio news, startup growth resources and industry insights

Home > News & Insights > From Series A to Celebrating BioCatch’s Next Chapter with Visa

From Series A to Celebrating BioCatch’s Next Chapter with Visa

Share

By Bruce Taragin and Yodfat Harel Buchris

Today’s announcement that Visa intends to acquire BioCatch for approximately $2.6 billion marks an important milestone for a company we have had the privilege of supporting since its earliest days. BioCatch has built a behavioral intelligence platform that helps financial institutions detect fraud in real time, protecting 1.8 billion devices and 760 million users globally. At the end of 2025, the company surpassed $185 million in annual recurring revenue.

For us, this announcement represents more than a successful outcome. It is a reminder that enduring companies are built through visionary founders, sustained execution, and long term partnerships.

Backing BioCatch From the Beginning

Blumberg Capital led BioCatch’s Series A because we believed financial fraud would become one of the defining challenges of the digital economy. As financial services became increasingly digital, we saw the need for a new approach to fraud prevention, one that combined cybersecurity, fintech, behavioral intelligence, and AI to help stop attacks before they could impact consumers and businesses.

BioCatch also reflects our long-time commitment to partnering early with exceptional Israeli founders building global technology companies. For three decades, Israel has been one of our core investment markets. We partner with entrepreneurs who combine deep technical expertise with the ambition to build global companies. BioCatch is a powerful example of the innovation emerging from Israel and why we remain committed to investing in its startup ecosystem.

Over the years, our partnership with BioCatch extended well beyond capital. We had the privilege of serving on the board, while our broader Blumberg Capital team worked alongside the BioCatch team, including leaders such as Gadi Mazor, Avi Turgeman and Howard Edelstein, to support customer introductions, strategic partnerships, recruiting, fundraising, and business development. Building a company of this scale requires an entire ecosystem of founders, employees, customers, investors, and partners working together over many years.

Why Behavioral Intelligence Matters More Than Ever

Today, BioCatch helps financial institutions combat account takeovers, scams, money mule activity, and application fraud using behavioral intelligence and AI. Visa’s acquisition underscores the growing importance of these capabilities as fraud becomes increasingly sophisticated. Visa has invested more than $13 billion in fraud technology and infrastructure over the past five years, and BioCatch’s technology is expected to strengthen its ability to help financial institutions stop fraud before it reaches the point of payment.

BioCatch reinforces several principles that have guided our investment strategy for decades:

  • Invest in exceptional founders early, particularly entrepreneurs building globally significant companies from leading innovation ecosystems, including Israel.
  • Invest at the intersection of major technology shifts, where cybersecurity, fintech, and AI create opportunities to solve mission critical problems.
  • Partner with founders for the long term, contributing capital, strategic guidance, customer introductions, and relationships that help companies scale.

Looking Ahead

Congratulations to the BioCatch team on this significant milestone. We are grateful to our fellow investors and shareholders who have supported the company over the years.

We are proud to have been part of BioCatch’s story from the beginning and look forward to seeing its technology protect even more businesses and consumers around the world as part of Visa.

Related Articles